We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAND
1276
Bandwidth Inc
BAND
$1.47B
$191K ﹤0.01%
11,487
+11,421
+17,305% +$176K
CTBI icon
1277
Community Trust Bancorp
CTBI
$1.44B
$191K ﹤0.01%
3,414
+3,229
+1,745% +$181K
AMP icon
1278
Ameriprise Financial
AMP
$49B
$191K ﹤0.01%
388
+161
+71% +$82.5K
EXPO icon
1279
Exponent
EXPO
$3.29B
$191K ﹤0.01%
2,743
+2,295
+512% +$164K
SLM icon
1280
SLM Corp
SLM
$5.21B
$190K ﹤0.01%
6,853
+6,174
+909% +$193K
FBK icon
1281
FB Financial Corp
FBK
$3.08B
$189K ﹤0.01%
+3,392
New +$172K
DIOD icon
1282
Diodes
DIOD
$4B
$189K ﹤0.01%
3,550
+2,771
+356% +$149K
SUPN icon
1283
Supernus Pharmaceuticals
SUPN
$2.57B
$188K ﹤0.01%
3,936
+3,868
+5,688% +$156K
ARLO icon
1284
Arlo Technologies
ARLO
$1.71B
$188K ﹤0.01%
+11,090
New +$188K
NAGE
1285
Niagen Bioscience
NAGE
$285M
$188K ﹤0.01%
+20,145
New +$203K
IRWD icon
1286
Ironwood Pharmaceuticals
IRWD
$729M
$188K ﹤0.01%
+143,392
New +$148K
PLGO
1287
Pelagos Insurance Capital
PLGO
$2.15B
$187K ﹤0.01%
+10,319
New +$172K
FOR icon
1288
Forestar Group
FOR
$1.49B
$187K ﹤0.01%
+7,023
New +$180K
BKR icon
1289
Baker Hughes
BKR
$60.8B
$187K ﹤0.01%
3,829
+2,690
+236% +$119K
DHIL
1290
DELISTED
Diamond Hill
DHIL
$186K ﹤0.01%
+1,332
New +$194K
AMTM
1291
Amentum Holdings
AMTM
$5.82B
$186K ﹤0.01%
7,760
+6,924
+828% +$169K
JAZZ icon
1292
Jazz Pharmaceuticals
JAZZ
$15.7B
$185K ﹤0.01%
1,407
+1,061
+307% +$127K
VOD icon
1293
Vodafone
VOD
$36.3B
$185K ﹤0.01%
15,970
+12,207
+324% +$139K
VIXY icon
1294
ProShares VIX Short-Term Futures ETF
VIXY
$189M
$183K ﹤0.01%
+5,680
New +$219K
MDY icon
1295
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$183K ﹤0.01%
307
+55
+22% +$32.3K
NABL icon
1296
N-able
NABL
$974M
$183K ﹤0.01%
23,402
+23,065
+6,844% +$185K
FMNB icon
1297
Farmers National Banc Corp
FMNB
$950M
$183K ﹤0.01%
12,665
+12,277
+3,164% +$176K
FLG
1298
Flagstar Bank National Association
FLG
$6.01B
$182K ﹤0.01%
15,747
-11,019
-41% -$131K
QTUM icon
1299
Defiance Quantum ETF
QTUM
$5.61B
$182K ﹤0.01%
2,278
+2,026
+804% +$194K
FMBH icon
1300
First Mid Bancshares
FMBH
$1.4B
$181K ﹤0.01%
+4,790
New +$187K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.